93 related articles for article (PubMed ID: 28041830)
1. Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit?
Fox C; Azores-Gococo D; Swart L; Holoch K; Savaris RF; Likes CE; Miller PB; Forstein DA; Lessey BA
Reprod Biomed Online; 2017 Mar; 34(3):319-324. PubMed ID: 28041830
[TBL] [Abstract][Full Text] [Related]
2. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotrophin (hCG) for preventing miscarriage.
Morley LC; Simpson N; Tang T
Cochrane Database Syst Rev; 2013 Jan; (1):CD008611. PubMed ID: 23440828
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial of the use of human chorionic gonadotrophin in recurrent miscarriage associated with polycystic ovaries.
Pearce JM; Hamid RI
Br J Obstet Gynaecol; 1994 Aug; 101(8):685-8. PubMed ID: 7947503
[TBL] [Abstract][Full Text] [Related]
5. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles.
Kyrou D; Fatemi HM; Popovic-Todorovic B; Van den Abbeel E; Camus M; Devroey P
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):175-9. PubMed ID: 20219279
[TBL] [Abstract][Full Text] [Related]
6. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
7. Modifying the luteal phase support in natural cycle frozen-thawed embryo transfer improves cycle outcome.
Haas J; Lantsberg D; Feldman N; Manela D; Machtinger R; Dar S; Rabinovici J; Orvieto R
Gynecol Endocrinol; 2015; 31(11):891-3. PubMed ID: 26288149
[TBL] [Abstract][Full Text] [Related]
8. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for threatened miscarriage.
Qureshi NS
Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial.
Quenby S; Farquharson RG
Fertil Steril; 1994 Oct; 62(4):708-10. PubMed ID: 7646609
[TBL] [Abstract][Full Text] [Related]
11. Improving the luteal phase after ovarian stimulation: reviewing new options.
Yding Andersen C; Vilbour Andersen K
Reprod Biomed Online; 2014 May; 28(5):552-9. PubMed ID: 24656557
[TBL] [Abstract][Full Text] [Related]
12. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
[TBL] [Abstract][Full Text] [Related]
13. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
Keenan JA; Moghissi KS
Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
[TBL] [Abstract][Full Text] [Related]
14. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
[TBL] [Abstract][Full Text] [Related]
16. Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.
Liu HC; Pyrgiotis E; Davis O; Rosenwaks Z
Early Pregnancy; 1995 Dec; 1(4):281-7. PubMed ID: 9363260
[TBL] [Abstract][Full Text] [Related]
17. Dydrogesterone in the reduction of recurrent spontaneous abortion.
El-Zibdeh MY
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of pregnancy in dairy cattle after treatment with human chorionic gonadotropin or gonadotropin-releasing hormone.
Stevenson JS; Tiffany SM; Inskeep EK
J Dairy Sci; 2008 Aug; 91(8):3092-101. PubMed ID: 18650285
[TBL] [Abstract][Full Text] [Related]
19. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase.
Lovely LP; Fazleabas AT; Fritz MA; McAdams DG; Lessey BA
J Clin Endocrinol Metab; 2005 Apr; 90(4):2351-6. PubMed ID: 15671112
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotrophin measurements in the luteal phase of the menstrual cycle of infertile and fertile women.
van Duren BP; Vemer HM; Thomas CM; Verhoef CG; Willemsen WN; Rolland R
Hum Reprod; 1988 Feb; 3(2):219-21. PubMed ID: 3356777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
